Michael Clay Majors Sells 37,000 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) EVP Michael Clay Majors sold 37,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the sale, the executive vice president directly owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Globe Life Trading Down 0.5%

Shares of NYSE:GL opened at $182.14 on Friday. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The company has a market capitalization of $14.14 billion, a PE ratio of 12.09 and a beta of 0.47. The business has a 50 day moving average of $171.52 and a two-hundred day moving average of $154.26. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts forecast that Globe Life Inc. will post 15.7 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on GL. Jefferies Financial Group raised their price target on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. JPMorgan Chase & Co. upped their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Truist Financial raised their target price on Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Finally, Keefe, Bruyette & Woods cut their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research note on Friday, July 24th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Globe Life presently has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. CYBER HORNET ETFs LLC acquired a new stake in Globe Life in the 2nd quarter worth about $28,000. Hilton Head Capital Partners LLC purchased a new stake in Globe Life during the 4th quarter worth approximately $30,000. MUFG Securities EMEA plc acquired a new position in shares of Globe Life during the second quarter valued at approximately $31,000. Torren Management LLC purchased a new position in shares of Globe Life in the fourth quarter valued at approximately $37,000. Finally, AdvisorNet Financial Inc lifted its position in shares of Globe Life by 41.1% in the first quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after acquiring an additional 92 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.